Valuation : Celltrion, Inc.

Market Cap 45,144B 33.52B 28.84B 27.14B 24.79B 46.38B 3,165B 46.5B 321B 124B 1,624B 126B 123B 5,231B P/E 2026 *
28.4x
P/E 2027 * 24.6x
Enterprise Value 47.38B 35.18M 30.27M 28.48M 26.02M 48.67M 3.32B 48.8M 337M 131M 1.7B 132M 129M 5.49B EV / Sales 2026 *
8.6x
EV / Sales 2027 * 7.36x
Free-Float
60.59%
Yield 2026 *
0.4%
Yield 2027 * 0.44%
1 day+0.53%
1 week-1.36%
Current month-0.42%
1 month+1.24%
3 months+6.57%
6 months+0.05%
Current year+9.12%
1 week 184,200
Extreme 184200
191,300
1 month 184,200
Extreme 184200
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-1.36%+16.04%+48.23% 33.52B
-2.54%-2.84%-1.90%+14.52% 48.93B
-0.40%+1.03%+439.20%+499.20% 45.01B
-1.42%+2.30%+45.46%+19.36% 44.07B
-1.22%-2.31%+12.40%+71.48% 40.73B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+22.59%+116.19% 16.5B
-1.01%+0.50%+15.83%+27.98% 14.67B
-1.65%-1.03%+77.75%+37.63% 13.77B
+0.78%-3.04%-6.53%-37.25% 12.72B
Average -0.75%+0.18%+68.98%+88.60% 28.77B
Weighted average by Cap. -0.95%-0.03%+90.08%+114.60%

Financials

2026 *2027 *
Net sales 5,509B 4.09B 3.52B 3.31B 3.03B 5.66B 386B 5.68B 39.14B 15.19B 198B 15.36B 15.03B 638B 6,329B 4.7B 4.04B 3.8B 3.48B 6.5B 444B 6.52B 44.96B 17.45B 228B 17.65B 17.26B 733B
Net income 1,531B 1.14B 978M 920M 841M 1.57B 107B 1.58B 10.87B 4.22B 55.05B 4.27B 4.17B 177B 1,772B 1.32B 1.13B 1.07B 973M 1.82B 124B 1.83B 12.59B 4.88B 63.73B 4.94B 4.83B 205B
Net Debt 2,232B 1.66B 1.43B 1.34B 1.23B 2.29B 157B 2.3B 15.86B 6.15B 80.3B 6.22B 6.09B 259B 1,415B 1.05B 904M 851M 777M 1.45B 99.23B 1.46B 10.05B 3.9B 50.91B 3.95B 3.86B 164B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-04 ₩188,100.00 +0.53% 270,580
26-09-03 ₩187,100.00 +0.43% 406,507
26-09-02 ₩186,300.00 -0.90% 299,403
26-09-01 ₩188,000.00 -0.48% 268,440
26-08-31 ₩188,900.00 -0.94% 643,636
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
188,100.00KRW
Average target price
267,626.15KRW
Spread / Average Target
+42.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock